Clinuvel Pharmaceuticals | CUV - Ebitda

Stock Price
8.95
Daily Change
-0.09 -1.00%
Monthly
-8.49%
Yearly
-17.21%
Q2 Forecast
8.87

Clinuvel Pharmaceuticals reported AUD27.55M in EBITDA for its fiscal semester ending in June of 2025.





Ebitda Change Date
Avita Medical AUD -9.69M 12.21M Dec/2025
Medical Developments International AUD 1.78M 3.78M Dec/2024
Mesoblast USD -20.3M 2.51M Dec/2025
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025
Pacific Edge NZD -13.97M 332K Sep/2024
Paradigm Biopharmaceuticals AUD -5.86M 3.79M Dec/2024
PYC Therapeutics AUD -22.79M 1.5M Dec/2025
Telix Pharmaceuticals AUD 18.42M 14.82M Dec/2025